Search results
Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
Investor's Business Daily· 55 minutes agoNovo Nordisk stock sank Thursday after sales of weight-loss blockbuster, Wegovy, nearly doubled year...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters via Yahoo News· 10 hours ago(Reuters) -U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for quarterly...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 54 minutes agoRegeneron stock jumped Thursday, bolstered by strong sales of a high-dose version of its blockbuster...
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
CNBC· 15 hours agoDanish pharmaceutical giant Novo Nordisk, which became the most valuable company in Europe last year...
Florida bans lab-grown meat, adding to similar efforts in four states
NBC News via Yahoo News· 18 minutes agoShapiro is the CEO of The Better Meat Co., which makes plant-based “meat” from fungi. “The...
... Turtles: Mutant Mayhem’ Shockingly Slays Way To No. 4 In Deadline’s 2023 Most Valuable ...
Deadline Hollywood· 2 hours agoDeadline’s Most Valuable Blockbuster tournament is back. While studios during Covid wildly embraced...
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Yahoo Finance via AOL· 4 hours agoNovo Nordisk (NVO) stock was trading down Thursday despite strong first quarter results, beating...
What's Going On With Enovix Stock After Earnings? - Enovix (NASDAQ:ENVX)
Benzinga· 5 hours agoEnovix Corporation ENVX shares are trading higher Thursday after the company posted...
Novo Nordisk Lifts Guidance as Blockbuster Drug Demand Shows No Signs of Abating — Update
Morningstar· 14 hours ago--the discount offered between the list price and the actual net sales price--related to previous years, it said Thursday. The company said sales of its blockbuster Ozempic ...
Wegovy sales more than doubled as the weight loss drug boom keeps powering Novo Nordisk
Quartz· 9 hours agoSales of the Danish pharma giant's obesity drugs grew 25% year over year in this year's first...